Cogent Biosciences, Inc. (COGT)
NASDAQ · Healthcare
Cogent Biosciences, Inc. Net Income 2017–2020
Cogent Biosciences, Inc. annual/quarterly net income history and growth rate from 2017 to 2020. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Cogent Biosciences, Inc. net income for the quarter ending September 30, 2020 was -50.0 M, a 319.21% increase year-over-year.
- Cogent Biosciences, Inc. net income for the twelve months ending September 30, 2020 was -75.4 M, a 82.12% increase year-over-year.
- Cogent Biosciences, Inc. annual net income for 2020 was -74.8 M, a 135.00% increase from 2019.
- Cogent Biosciences, Inc. annual net income for 2019 was -31.8 M, a 7.82% decrease from 2018.
- Cogent Biosciences, Inc. annual net income for 2018 was -34.5 M, a 35.46% increase from 2017.
- Cogent Biosciences, Inc. annual net income for 2017 was -25.5 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cogent Biosciences, Inc. Net Income — FAQ
Cogent Biosciences, Inc. (COGT) net income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Cogent Biosciences, Inc.'s net income?
Cogent Biosciences, Inc. (COGT) reported net income of -$75M for fiscal 2020.
Where can I see COGT's net income history?
The chart and table above show Cogent Biosciences, Inc.'s net income by year and by quarter, including the growth rate.